BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4948540)

  • 1. [Sensitivity of gram negative bacilli to lincomycin and erythromycin in alkaline media].
    Yourassowsky E
    Acta Clin Belg Suppl; 1971; 7():41-4. PubMed ID: 4948540
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross resistance between lincomycin and erythromycin in viridans streptococci.
    Sprunt K; Leidy G; Redman W
    Pediatrics; 1970 Jul; 46(1):84-8. PubMed ID: 5423461
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhanced activity of novobiocin against gram-negative bacilli in acid media.
    Sabath LD; Gerstein DA; Finland M
    Antimicrob Agents Chemother (Bethesda); 1968; 8():398-404. PubMed ID: 4898534
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibacterial activity in vitro of a new rifamycin: rifamide].
    Monnier J; Bourse R
    Pathol Biol; 1968 Oct; 16(19):901-8. PubMed ID: 4972879
    [No Abstract]   [Full Text] [Related]  

  • 5. Excretion of erythromycin and its enhanced activity in urine against gram-negative bacilli with alkalinization.
    Sabath LD; Gerstein DA; Loder PB; Finland M
    J Lab Clin Med; 1968 Dec; 72(6):916-23. PubMed ID: 4972710
    [No Abstract]   [Full Text] [Related]  

  • 6. Kinetics and mechanisms of action of drugs on microorganisms. XVI. Effect of oleandomycin and its combinations with tetracycline, chloramphenicol, erythromycin, lincomycin, and 1'-demethyl-4'-depropyl-4'-(R and S)-n-pentylclindamycin on microbial generation of Escherichia coli.
    Won CM; Garrett ER
    J Pharm Sci; 1973 Jul; 62(7):1087-92. PubMed ID: 4576800
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitivity of Escherichia coli after exposure to lincomycin in vitro and in vivo.
    DeGeeter MJ; Stahl GL
    Am J Vet Res; 1976 May; 37(5):531-4. PubMed ID: 776050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics and mechanisms of action of drugs on microorganisms. XI. Effect of erythromycin and its supposed antagonism with lincomycin on the microbial growth of Escherichia coli.
    Garrett ER; Heman-Ackah SM; Perry GL
    J Pharm Sci; 1970 Oct; 59(10):1448-56. PubMed ID: 4919444
    [No Abstract]   [Full Text] [Related]  

  • 9. [Streptococcus pyogenes group A--sensitivity to chemical preparations in vitro].
    Výmola F; Jedlicková Z
    Cas Lek Cesk; 1972 Mar; 111(13):292-4. PubMed ID: 4552005
    [No Abstract]   [Full Text] [Related]  

  • 10. ["In vitro" activity of gentamicin on some gram-negative and gram-positive strains and on mycobacterium strains].
    Velluti G; Valentini L
    G Ital Chemioter; 1969; 16(1):74-82. PubMed ID: 4998312
    [No Abstract]   [Full Text] [Related]  

  • 11. Kinetics and mechanisms of action of drugs on microorganisms. XV. Effect of erythromycin on the action of lincomycin (Phase II) and the 7 (S)-chloro analogs of lincomycin against Escherichia coli.
    Heman-Ackah SM; Garrett ER
    J Pharm Sci; 1972 Apr; 61(4):545-51. PubMed ID: 4552281
    [No Abstract]   [Full Text] [Related]  

  • 12. Rosamicin: evaluation in vitro and comparison with erythromycin and lincomycin.
    Crowe CC; Sanders WE
    Antimicrob Agents Chemother; 1974 Mar; 5(3):272-5. PubMed ID: 4840436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of Staphylococcus aureus to lincomycin, clinimycin, and erythromycin.
    McGehee RF R; Barre FF; Finland M
    Antimicrob Agents Chemother (Bethesda); 1968; 8():392-7. PubMed ID: 5735385
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative studies on biological activity in vitro of beta hydroxyethylpiperazin-methyltetracycline phenoxymethypenicillinate, phenoxymethylpenicillin, cloxacillin, erythromycin lactobionate, linkomycin, and tetracycline].
    Chojnowski W
    Acta Pol Pharm; 1971; 28(4):429-32. PubMed ID: 5004318
    [No Abstract]   [Full Text] [Related]  

  • 15. Sponaneous loss of resistance to kanamycin and other antibiotics in methicillin-resistant cultures of Staphylococcus aureus.
    Annear DI; Grubb WB
    Med J Aust; 1969 Nov; 2(18):902-4. PubMed ID: 5196123
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro susceptibility and resistance of gram negative bacilli to carbenicillin.
    Athar MA
    Hindustan Antibiot Bull; 1970; 13(1):1-7. PubMed ID: 4993698
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment with maximal tolerated doses of antibiotics. II. Chloramphenicol, lincomycin, and other preparations].
    Vacek V; Hejzlar M; Stafová J
    Cas Lek Cesk; 1968; 107(44):1316-9. PubMed ID: 4971814
    [No Abstract]   [Full Text] [Related]  

  • 18. Microbial kinetics of drug action against gram-positive and gram-negative organisms. I. Effect of lincomycin on Staphylococcus aureus and Escherichia coli.
    Heman-Ackah SM
    J Pharm Sci; 1974 Jul; 63(7):1077-84. PubMed ID: 4604772
    [No Abstract]   [Full Text] [Related]  

  • 19. Variety in the response of Escherichia coli to erythromycin.
    Greenwood D; O'Grady F
    J Med Microbiol; 1972 Aug; 5(3):321-6. PubMed ID: 4560749
    [No Abstract]   [Full Text] [Related]  

  • 20. Kinetics and mechanisms of drug action on microorganisms. XX. Integrated receptor site model rationalizing observed microbial rate dependencies on drug concentration and microbial kinetics affected by sodium fusidate.
    Garrett ER; Richard AJ
    J Pharm Sci; 1974 Jun; 63(6):884-94. PubMed ID: 4604661
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.